News Headlines Article

At $1,000 per pill, Gilead’s hepatitis C drug has insurers, others scratching their heads
San Francisco Business Times

A new “miracle drug” is raising eyebrows across the health universe not because of its ability to cure hepatitis C, but because of its price tag. At $1,000 per pill, Sovaldi has Oregon insurers, both in the public and private spheres, scrambling to figure out if and when to cover the treatment. “Like so many people all across this country, we’re in the middle of evaluating both the efficacy of current screening options for hepatitis C and the most appropriate protocols for Sovaldi,” said Jonathan Nicholas, spokesman for Moda Health insurance.